Skip to content

Voices of Patients' Relatives to Support Weaning From Mechanical Ventilation

Voices of Patients' Relatives to Support Weaning From Mechanical Ventilation in Patients With Severe Brain Injury - VOICE-WEANING, a Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03795623
Acronym
VOICE-WEANING
Enrollment
45
Registered
2019-01-08
Start date
2019-02-01
Completion date
2021-04-30
Last updated
2023-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries, Ventilator Weaning, Weaning Failure

Keywords

Critical Illness, Respiration Disorder, Neurology

Brief summary

Patients with severe brain injuries, such as ischemic stroke and intracranial hemorrhage, frequently require mechanical ventilation. Weaning of stroke patients is complicated by impaired consciousness and respiratory drive. Higher rates of weaning failure and delayed extubation (≥ 48h) lead to ventilator associated pneumonia, higher mortality and necessity of tracheostomy. Therefore, improving the weaning of stroke patients from mechanical ventilation is warranted to prevent ventilator-associated complications and eventually improve clinical outcomes. This single-center, randomized, clinical trial aims at demonstrating that voices of patients' relatives support weaning from mechanical ventilation and reduce weaning failure in brain-injured patients.

Detailed description

Methods: Adult ICU-patients with controlled mechanical ventilation ≥48h due to a neurological disease will be included in the intensive care unit. A predefined text - including information on the patient's condition and recurrent request to breath in and out - will be recorded as an audio file by one of the patient's relatives. Patients will be randomly assigned in a 1:1 ratio to the conventional treatment arm or the Voice-Weaning arm. In the conventional arm, audio recordings will be muted by an independent person resulting in a mute recording without audio signals. When conversion from controlled to assisted mechanical ventilation is intended according to standard treatment, audio recordings will be administered in repeat mode for 10 minutes and performed three times per day. If spontaneous breathing trials (SBT) are intended according to standard treatment, the audio recordings will be played during the SBT three times per day. Criteria for weaning not to be intended - according to Boles et al. (Weaning from mechanical ventilation. Eur Respir J. 2007) and adapted to neurological patients: Objective measurements: * Unstable clinical condition * Cardiovascular status (fC≥140/min, systolic BP \<90mmHg or \>180mmHg, more than minimal vasopressors) * Metabolic status (e.g. inacceptable electrolytes) * Inadequate oxygenation * SaO2 ≤90% on FiO2 \>40% or pO2/FiO2 \<150mmHg or pO2/FiO2 \<120mmHg in case of chronic hypoxemia (Horowitz index) * PEEP\>8cmH2O * Inadequate pulmonary function * fR ≥35/min * MIP\>(-20 -) -25cmH2O * VT ≤5ml/kgKG * VC ≤10ml/kgKG * fR/VT ≥105 breaths/min x l (RSBI) * significant respiratory acidosis (pH≤7.25) * Unstable neurological condition * sedation or inadequate mentation on sedation * present or anticipated intracranial mass effect (e.g. midline shift \>10mm or progression, basal cistern effacement or oculomotor disturbance, signs of transfalxial/transtentorial/transforaminal herniation * elevation of intracranial pressure (\>20 cmH2O) and/or obstructive hydrocephalus * severe vasospasms (\>6 kHz in transcranial Doppler, or determined by CT-A/CT-P) * status epilepticus (determined by EEG) * acute intracranial infection (without established and/or treated origin) Clinical assessment: * Inadequate cough * Excessive tracheobronchial secretion * Disease acute phase for which the patient was intubated Ethics Approval: The Institutional Review Board of the Friedrich-Alexander-Universität Erlangen-Nürnberg approved of the study on 13 November 2018. Sample Size Calculation: The sample size is computed with 80% power and a 5% α-risk for the hypothesis of Voice Weaning achieving a 15% absolute weaning failure reduction. The sample size is increased by 10% to correct for dropouts and lost to follow up: a maximum of 354 patients will be included and an interim analysis be performed after inclusion of 50% of the calculated subjects.

Interventions

OTHERVoice-Weaning

Audio recordings of patients' relatives for 10 minutes x 3 daily from initiation of assisted mechanical ventilation to extubation or ICU discharge.

OTHERSham control

Muted audio recordings of patients' relatives for 10 minutes x 3 daily from initiation of assisted mechanical ventilation to extubation or ICU discharge.

Sponsors

University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Intubation and controlled mechanical ventilation ≥48h due to a neurological disease * Weaning from mechanical ventilation intended by the attending physician * Obtained informed consent from the legal representative

Exclusion criteria

* Age \< 18 years * History of psychiatric disease * Weaning from mechanical ventilation not intended or decision to limit therapeutic interventions

Design outcomes

Primary

MeasureTime frameDescription
Rate of weaning failurefirst 28 days after start of ventilation, or until 48 hours after extubation, or discharge from intensive care, whichever came firstReintubation and/or resumption of ventilatory support following extubation or death following extubation or failed spontaneous breathing trial

Secondary

MeasureTime frameDescription
Time of controlled ventilationfirst 28 days after start of ventilation or discharge from intensive care, whichever came first
Rate of tracheotomyfirst 28 days after start of ventilation or discharge from intensive care, whichever came firstProportion of patients requiring tracheotomy performed as percutaneous dilatative tracheotomy or surgical tracheotomy
All cause mortality rate at 90 daysfirst 90 days after start of ventilation
Rate of ICU deliriumfirst 28 days after start of ventilation or discharge from intensive care, whichever came firstDevelopment of delirium according to the Confusion Assessment Method for intensive care unit (CAM-ICU)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026